Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Bittner, Stefan; Wiendl, Heinz

Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications

NEUROTHERAPEUTICS. Bd. 13. H. 1. 2016 S. 4-19



Bell, Katharina; Wilding, Corina; Funke, Sebastian et al.

Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture

JOURNAL OF NEUROCHEMISTRY. Bd. 139. H. 2. 2016 S. 256-269


Ward, Peter A.; Fattahi, Fatemeh; Bosmann, Markus

New Insights into Molecular Mechanisms of Immune Complex-Induced Injury in Lung

FRONTIERS IN IMMUNOLOGY. Bd. 7. 2016


Hahn, Matthias; Macht, Anna; Waisman, Ari et al.

NF-kappa B-inducing kinase is essential for B-cell maintenance in mice

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. H. 3. 2016 S. 732-741


Kerstan, A.; Alrefai, H.; Muhammad, K. et al.

NFATc1 promotes imiquimod-induced skin inflammation by negatively controlling IL-10 production in B cells

EXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E26-E26


Busch, Rhoda; Murti, Krisna; Liu, Jiming et al.

NFATc1 releases BCL6-dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. H. 3. 2016 S. 634-646


Muhammad, K.; Alrefai, H.; Rudolf, R. et al.

NFATc1 supports imiquimod- induced skin inflammation by suppressing regulatory B cells

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. 2016 S. 1136-1136


Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells

NATURE COMMUNICATIONS. Bd. 7. 2016


Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.

NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells (vol 7, 11724, 2016)

Nature Communications. Bd. 7. 2016